3Hernamdo J J, Dark T W, Kubler K, et al.Vaccination with autologons tumor atigenpulsed dendritric cells in advanced gynaecological malignancies, clinical and inmunological evaluation of a phase I trial[J].Cancer Imonumol Immunother,2002,51 (1):45-52.
4Giuntoli R L, Metzingre D S,Dimarco C S,et al. Retrospective review of 208 patients with leiomyosarcoma of the uterus:prognostic indicators, surgical management ,and adjuvant therapy [J].Gynecol onclo,2002 J,89(3):460-469.
5Olah K S, Gee H, Dunn J, et al. Retrospective analysis of 318 csses of uterine sarcoma [J]. Eur J Cancer, 1991,32(27):1095-1099.
6Levenback C F, Tortolen-Luna G, Pandey D K, et al. Uterine sarcoma[J]. Obster GynecokClin North Am, 1996,10 (23):457-473.
7Knocke T H, Kucera H, Dorfler D,et al.Result of Postoperative radiotherapy in the treatment of sarcoma of the corpus uterine [J].Cancer, 1998, 7(83): 1972 - 1979.
8Soimarova R, Horova H,Seneklova Z, et al.Treatment of uterine sarcoma. A survey of 49 patients[J].Arch Gynecol Obster, 2002,266(2):92-95.
9Kushner D M ,Webster K D ,Belinson J L,et al .Safety and efficiency of adjuvant single-agent lfosmamide in unerine sarcoma [J]. Gynecol Oncol,2002, 8 (2): 221-227.
10Gnegory S, John A B, John H M. Lfosfamide and doxoncbicin in the treatment of advanced leiomyosarcomas of the uterines [J]. Gynecol Onco1,1996, 16(62):226-229.
